The Introduction of AI-Powered Chatbots in Pharmacy Practice

By HEOR Staff Writer

October 11, 2023

The Encouraging Possibilities Offered by ChatGPT

The field of healthcare is one of the many industries that has been significantly advanced by the application of artificial intelligence (AI). A recent study sheds light on the potential of chatbots driven by artificial intelligence, notably ChatGPT, to revolutionise the practice of pharmacy. Patients can receive assistance from ChatGPT, a conversational bot, which responds to questions regarding their health and offers individualised guidance. The efficacy of this technology, on the other hand, is highly dependent on the level of expertise of the pharmacists who use it.

AI-powered Chatbots in Pharmacy Practice

According to the findings of the study, the majority of participants were aware of the possible advantages that ChatGPT could provide to the pharmaceutical industry. They were all in agreement that ChatGPT might be of tremendous use to pharmacists, particularly in terms of creating ideas connected to pharmaceutical marketing and offering educational information relating to pharmacy items or therapeutic areas.

Concerns Should Be Addressed and Use Made More Efficiently

While it is clear that ChatGPT may have some positive applications, the study also brought to light several possible drawbacks and concerns. These include the possibility of inaccuracies in the responses provided by ChatGPT, concerns regarding privacy brought on by the gathering and processing of data, and the possibility that AI systems will learn and reproduce prejudices based on the information they are trained on. These concerns highlight the necessity for careful implementation of AI systems, strict security measures, and regular monitoring.

Conclusion

A generally good impression of ChatGPT’s prospective function in the pharmaceutical sector was revealed by the findings of the study, notwithstanding the reservations that were raised. The findings imply that the issues can be minimized and the benefits of AI-powered chatbots can be improved in pharmacy practice through increased awareness, correct information, and user education.

Reference url

Recent Posts

EU Approves Imfinzi Gastric Cancer Treatment as Perioperative Immunotherapy

By João L. Carapinha

March 17, 2026

Imfinzi gastric cancer treatment has received European Commission approval for adults with resectable, early-stage and locally advanced (Stages II, III, IVA) gastric and gastroesophageal junction (GEJ) cancers. AstraZeneca’s Imfinzi (durvalumab), a PD-L1 inhibitor, combined with FLOT chemotherapy...
EU Medicines Regulation Achievements: EMA’s 2025 Highlights and Future Directions

By HEOR Staff Writer

March 16, 2026

The European Medicines Agency (EMA) Management Board highlights at its March 2026 meeting a robust year, with the adoption of the 2025 annual report detailing 104 positive recommendations for new hu...
FDA Biosimilar Approval Reforms: Accelerating Access and Reducing Drug Costs

By HEOR Staff Writer

March 11, 2026

The US Food and Drug Administration (FDA) has introduced biosimilar approval reforms to accelerate development and adoption, tackling biologic drug costs that exceeded 50% of total US drug spending in 2024. These biosimilar approval reforms address burdensome criteria stifling uptake, despite 82 ...